Innovative #MedicinalChemistry introduces new worlds of #DrugDiscovery to those at the cutting edge ➡ Enter code SCORRVIP2022 for 20% off our KOL Pass and connect with leaders in #DrugDiscovery on everything from novel modalities to undruggable. https://t.co/ihQfzQgwGQ
AI integration. Next-gen cell models. Our strategy meeting offers guidance and builds partnerships among leaders in #DrugDiscovery ➡ Enter code SCORRVIP2022 for 20% off a KOL Pass and start connecting! https://t.co/cfdq1ohVwr
Open up your toolkit to the latest innovations in #MedicinalChemistry ➡ Enter code SCORRVIP2022 for 20% off our KOL Pass and connect with leaders in #DrugDiscovery on everything from novel modalities to cheminformatics. https://t.co/m0DCkFCm1m
How has our strategy meeting become an epicenter of #DrugDiscovery discourse? Because it is built on real conversations ➡ Enter code SCORRVIP2022 for 20% off a KOL pass. Discuss the latest with industry leaders! https://t.co/Hr5pAxHdoL
The path to market can be volatile. What offers insight? Real conversations with those shaping the future of regulatory strategy ➡ Enter code SCORRVIP2022 for a 20% discount off our KOL Pass. https://t.co/Bl60xOOTFo
Have you unlocked the potential of your network? Our roundtables are returning to the U.S., inspiring industries through conversation! https://t.co/WFdXsRWL5U
Uncover novel opportunities in #ClinOps ➡ Enter code SCORRVIP2022 for 20% off our KOL Pass and open your eyes to the biggest innovations in everything from AI automation to groundbreaking #eCOA. https://t.co/CJaWS1wbmK
Are you keeping pace? Oncology is advancing rapidly, powered by precision medicine and genome editing ➡ Enter code SCORRVIP2022 for 20% off our KOL Pass. Discuss the latest with real industry leaders! https://t.co/LEfbZBIffq
How is the industry responding to innovation? What’s working? What isn’t? Our roundtables have returned — facilitated by renown thought leaders! https://t.co/YJr6lBrOyX
Dissecting DCTs. Examining novel modalities. Imagining the future of bioinformatics. All in conversation. Our roundtables have returned to the U.S.! https://t.co/sas3GFzFXl
Battling data availability? Chasing targets for inhibitors? Our roundtable introduces you to the people and procedures confronting these problems. https://t.co/aHLu6MMBDH
Your network can be so powerful, but building it isn’t easy. Our roundtables act as direct lines to industry leaders — now back in the U.S.! https://t.co/dm6WND5ntB
Struggling with inclusivity? Struggling to fully optimise IRT? Our roundtable introduces you to the #ClinOps innovations that matter most! https://t.co/jK00q8Le6X
Regulation is complex, but the right strategies can streamline your process. Which solutions are proving successful? Join the conversation! https://t.co/CW2P097r21
From patient-centric technology to risk-based monitoring, our roundtable is dissecting the most insightful and useful advancements in #ClinOps! https://t.co/yae4G4DZPT
Regulation can be convoluted, but novel strategies can streamline and simplify. Join the conversation on which approach accelerates approvals! https://t.co/3T6EhMokxJ
Do you know which advances in #MedicinalChemistry are suited for your studies — leveraging AI or predictive targeting? Our roundtable has answers! https://t.co/P62NnPpgp6
AI toxicity testing. Metabolism diversity. The leaders of #DrugDiscovery push our understanding forward, and we are kickstarting the conversation! https://t.co/5xht6EMrpL
Regulation is complex, but the right strategies can streamline your process. Which solutions are proving successful? Join the conversation! https://t.co/EdgUXuobL4
There is no shortage of progress in #ClinOps. The difficulty lies in discerning which innovations yield more clinical success. Join the conversation! https://t.co/flZDz6H7u3